Diazyme Laboratories
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12889 Gregg Ct, Poway, California, 92064...Phone Number
(858) 455-4768Website
www.diazyme.comRevenue
$15.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Diazyme Laboratories
Diadexus, Inc., a diagnostics company, focuses on the development and commercialization of cardiovascular diagnostic products addressing needs in cardiovascular disease. Its products include PLAC ELISA Test and the PLAC Activity Test that are designed to provide information on traditional risk factors, such as cholesterol levels to help identify individuals at risk of suffering a heart attack or stroke. The companys PLAC ELISA Test is an aid in predicting risk for coronary heart disease (CHD) and ischemic strokes associated with atherosclerosis; and PLAC Test for Lp-PLA2 (lipoprotein-associated phospholipase A2) Activity is used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of CHD in patients with no prior history of cardiovascular events. Its pipeline of proprietary biomarkers comprises proADM, proET-1, and proANP for the treatment of heart failure. The company markets its products to various national and regional clinical reference lRead more
Diazyme Laboratories Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diazyme Laboratories your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Diazyme Laboratories recently announced quarterly report
Check if Diazyme Laboratories has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Diazyme Laboratories launches new products
Funding: Get notified immidiatlly once Diazyme Laboratories has new funding data
Click to see if Diazyme Laboratories had a recent Job posting/layoffs
Check out if Diazyme Laboratories is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Diazyme Laboratories, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Diazyme Laboratories
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Diazyme Laboratories
Compare insights from companies similar to Diazyme Laboratories, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Diazyme Laboratories
$15.9M
11-50
Private
-
2000
SO
Steve O'HaraVice President, Finance & Administration
Company Profile Activity
Activity Insights
Diazyme Laboratories is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Diazyme Laboratories is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Diazyme Laboratories.
Diazyme Laboratories Tech Stack
A closer look at the technologies used by Diazyme Laboratories
Most Recent Scoops
Hiring Plans
Diazyme Laboratories has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Event
Product Marketing, Events, Training, Sales, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology, HR Operations, Operations
Open Position
Open Position
Open Position
Diazyme Laboratories News & Media
Glycated Albumin Assay Market is Projected to Potential at a 7.7% CAGR by 2028 | Diazyme, LifeSpan BioSciences
SEATTLE, UNITED STATES, UNITED STATES, January 7, 2022 /EINPresswire.com/ -- New Research Study "Glycated Albumin Assay Market Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment …Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a high throughput chemiluminescent immunoassay with excellent correlation to a fluorescence based neutralization assay, which has been used to evaluate the adaptive immune response in vaccine studies1. Diazyme also announced plans to work with US FDA for EUA application.Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- Diazyme announces that it has received a reissued Emergency Use Authorization (EUA) for its Semi-Quantitative DZ-Lite SARS-CoV-2 IgG CLIA test which is run on the fully automated DZ-Lite 3000 Plus chemiluminescence analyzer. The FDA has already granted Diazyme an EUA for its qualitative DZ-Lite SARS-CoV-2 IgG CLIA test (July, 2020). Upon reviewing additional data, the FDA has authorized the Diazyme IgG assay to be used as aDiazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on the fully automated DZ-Lite 3000 Plus chemiluminescence analyzer.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diazyme Laboratories
Sign Up For FreeTo access detailed company insights
Diadexus, Inc., a diagnostics company, focuses on the development and commercialization of cardiovascular diagnostic products addressing needs in cardiovascular disease. Its products include PLAC ELISA Test and the PLAC Activity Test that are designed to provide information on traditional risk factors, such as cholesterol levels to help identify in... Read More
